Securian Asset Management, Inc Catalent, Inc. Transaction History

Securian Asset Management, Inc

$3.43 Billion
Q3 2024

A detailed history of Securian Asset Management, Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Securian Asset Management, Inc holds 9,900 shares of CTLT stock, worth $628,452. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,900

Previous 10,314 4.01%

Holding current value

$628,452

Previous $579,000 3.45%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$56.16 - $60.96 $23,250 - $25,237	-414 Reduced 4.01%	9,900 $599,000
Q2 2024 Jul 15, 2024	SELL	$53.58 - $57.02 $17,681 - $18,816	-330 Reduced 3.1%	10,314 $579,000
Q1 2024 Apr 26, 2024	SELL	$42.56 - $59.82 $30,089 - $42,292	-707 Reduced 6.23%	10,644 $600,000
Q4 2023 Feb 08, 2024	SELL	$32.18 - $46.57 $48,623 - $70,367	-1,511 Reduced 11.75%	11,351 $510,000
Q3 2023 Oct 30, 2023	SELL	$44.2 - $50.2 $76,554 - $86,946	-1,732 Reduced 11.87%	12,862 $585,000
Q2 2023 Aug 07, 2023	SELL	$31.86 - $67.26 $6,372 - $13,452	-200 Reduced 1.35%	14,594 $632,000
Q4 2022 Feb 02, 2023	BUY	$41.39 - $81.0 $1,821 - $3,564	44 Added 0.3%	14,794 $665,000
Q3 2022 Oct 28, 2022	SELL	$72.36 - $113.1 $7,236 - $11,310	-100 Reduced 0.67%	14,750 $1.07 Million
Q2 2022 Aug 04, 2022	SELL	$87.2 - $114.05 $8,720 - $11,405	-100 Reduced 0.67%	14,850 $1.59 Million
Q1 2022 May 03, 2022	BUY	$94.19 - $124.49 $49,638 - $65,606	527 Added 3.65%	14,950 $1.66 Million
Q4 2021 Feb 10, 2022	SELL	$119.57 - $139.07 $17,337 - $20,165	-145 Reduced 1.0%	14,423 $1.85 Million
Q3 2021 Nov 08, 2021	SELL	$109.17 - $142.35 $32,751 - $42,705	-300 Reduced 2.02%	14,568 $1.94 Million
Q2 2021 Aug 10, 2021	BUY	$100.34 - $115.69 $802 - $925	8 Added 0.05%	14,868 $1.61 Million
Q1 2021 May 10, 2021	SELL	$101.51 - $125.27 $13,094 - $16,159	-129 Reduced 0.86%	14,860 $1.57 Million
Q4 2020 Feb 08, 2021	SELL	$85.88 - $105.36 $19,752 - $24,232	-230 Reduced 1.51%	14,989 $1.56 Million
Q3 2020 Nov 04, 2020	SELL	$72.74 - $92.5 $90,052 - $114,515	-1,238 Reduced 7.52%	15,219 $1.3 Million
Q2 2020 Aug 06, 2020	BUY	$48.02 - $79.04 $25,066 - $41,258	522 Added 3.28%	16,457 $1.21 Million
Q1 2020 May 07, 2020	BUY	$36.95 - $62.95 $33,809 - $57,599	915 Added 6.09%	15,935 $828,000
Q4 2019 Feb 04, 2020	SELL	$47.06 - $56.64 $64,472 - $77,596	-1,370 Reduced 8.36%	15,020 $846,000
Q3 2019 Nov 12, 2019	SELL	$47.45 - $58.05 $52,669 - $64,435	-1,110 Reduced 6.34%	16,390 $781,000
Q2 2019 Aug 05, 2019	SELL	$39.26 - $54.21 $8,480 - $11,709	-216 Reduced 1.22%	17,500 $949,000
Q3 2018 Oct 26, 2018	BUY	$40.12 - $45.55 $45,736 - $51,927	1,140 Added 6.88%	17,716 $807,000
Q2 2018 Aug 09, 2018	BUY	$38.72 - $42.52 $8,208 - $9,014	212 Added 1.3%	16,576 $694,000
Q4 2017 Feb 05, 2018	SELL	$37.27 - $43.02 $10,100 - $11,658	-271 Reduced 1.63%	16,364 $672,000
Q3 2017 Nov 03, 2017	BUY	$33.75 - $41.67 $29,025 - $35,836	860 Added 5.45%	16,635 $664,000
Q2 2017 Aug 14, 2017	BUY	N/A	15,775	15,775 $554,000

Others Institutions Holding CTLT

# of Institutions

515

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.

Account

Securian Asset Management, Inc Catalent, Inc. Transaction History